| Literature DB >> 29132427 |
Irina Gringauz1,2, Yael Shemesh3,2, Amir Dagan1,2, Irina Israelov1,2, Dana Feldman1,2, Naama Pelz-Sinvani1,2, Dan Justo4,2, Gad Segal5,6.
Abstract
BACKGROUND: Falls during hospitalization harbor both clinical and financial outcomes. The modified Morse fall scale [MMFS] is widely used for an in-hospital risk-of-fall assessment. Nevertheless, the majority of patients at risk of falling, i.e. with high MMFS, do not fall. The aim of this study was to ascertain our study hypothesis that certain patients' characteristics (e.g. serum electrolytes, usage of a walking device etc.) could further stratify the risk of falls among hospitalized patients with MMFS.Entities:
Keywords: Falls; Hospitalization; Morse Fall Scale; Risk stratification
Mesh:
Year: 2017 PMID: 29132427 PMCID: PMC5684764 DOI: 10.1186/s12913-017-2685-2
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
A modified Morse scale for risk assessment used in the Chaim Sheba Medical Center
| Category | Score for "Yes" | Score for "No" |
|---|---|---|
| Does the patient take more than 4 different medications? | 1 | 0 |
| Treatment with specific medications (cumulative score) | ||
| Anti-histamine | 1 | 0 |
| Anti-hypertensive | 1 | 0 |
| Diuretics | 1 | 0 |
| Medications interfering with the state of alertness | 1 | 0 |
| Psychiatric medications | 1 | 0 |
| Laxatives | 1 | 0 |
| Anti-diabetic medications | 1 | 0 |
| Level of consciousness | ||
| Mild confusion | 1 | 0 |
| Confused | 1 | 0 |
| Vaguely conscious | 1 | 0 |
| Unconscious | 1 | 0 |
| Sedated | 1 | 0 |
| Under the influence of medications | 1 | 0 |
| Cognitive state | ||
| Difficulties in orientation, time | 1 | 0 |
| Difficulties in orientation, place | 1 | 0 |
| Difficulties in orientation, people | 1 | 0 |
| Memory problems | 1 | 0 |
| Vision | ||
| Normal/Sedated | 0 | |
| Difficulties in vision | 1 | 0 |
| Eyeglasses all day long | 1 | 0 |
| Blindness | 1 | 0 |
| Hearing | ||
| Normal/Sedated | 0 | |
| Difficulties in hearing | 1 | 0 |
| Hearing aid all day long | ||
| Deafness | 1 | 0 |
| Mobility | ||
| Fully independent/bedridden | 0 | |
| Needs little help | 1 | 0 |
| Needs significant help | 1 | 0 |
| Needs much help | 1 | 0 |
| Walking and stability | ||
| Walks stably | 0 | |
| Weakness | 1 | 0 |
| Instability | 1 | 0 |
| Paralyzed | 1 | 0 |
| Bedridden | 1 | 0 |
| Wheelchair | 1 | 0 |
| Patient attached to limiting equipment (e.g., infusion set apparatus) | 1 | 0 |
| Use of mobility aids | ||
| Does not use | 0 | |
| Cane | 1 | 0 |
| Walks with the help of the nursing staff | 1 | 0 |
| Walker | 1 | 0 |
| Wheelchair | 1 | 0 |
| Crutches | 1 | 0 |
| Amputation/Artificial limb | 1 | 0 |
| History of falling during the past 6 months | 9 | 0 |
| Difficulty in getting out of a bed or a chair | 1 | 0 |
| Patient feels weaker than before | 1 | 0 |
| Patient feels dizzy | 1 | 0 |
| Patient has decreased leg sensation | 1 | 0 |
| Did the patient undergo general anesthesia during the past 24 hours? | 1 | 0 |
| Urgency and a high frequency of the need to go to the toilet | 1 | 0 |
| Does the patient go to the toilet during the night-time? | 1 | 0 |
Clinical characteristics of the whole cohort
| Total | Fallers | Non-fallers | Relative risk |
| |
|---|---|---|---|---|---|
| Demographics and chronic co-morbidities | |||||
| Age, years, mean±SD | 76.8±14.0 | 75.0±13.2 | 77.7±14.3 | / | 0.062 |
| Men, | 210 (49.1) | 77 (55.4) | 133 (46.0) | 1.4 (0.9-2.1) | 0.079 |
| Hypertension, | 278 (65.0) | 89 (64.0) | 189 (65.4) | 0.9 (0.6-1.4) | 0.829 |
| Ischemic heart disease, | 149 (35.0) | 54 (39.1) | 95 (33.0) | 1.3 (0.8-1.9) | 0.233 |
| Atrial fibrillation, | 100 (23.4) | 26 (18.7) | 74 (25.6) | 0.6 (0.4-1.1) | 0.143 |
| Diabetes mellitus, | 163 (38.1) | 59 (42.4) | 104 (36.0) | 1.3 (0.8-1.9) | 0.204 |
| Dementia, | 66 (15.4) | 17 (12.2) | 49 (17.0) | 0.6 (0.3-1.2) | 0.253 |
| Congestive heart failure, | 103 (24.1) | 36 (25.9) | 67 (23.2) | 1.1 (0.7-1.8) | 0.548 |
| Chronic renal failure, | 142 (33.3) | 55 (39.6) | 87 (30.2) | 1.5 (0.9-2.3) | 0.062 |
| Post-stroke, | 91 (21.3) | 28 (20.1) | 63 (21.8) | 0.9 (0.5-1.4) | 0.801 |
| Chronic lung disease, | 45 (10.5) | 19 (13.8) | 26 (9.0) | 1.6 (0.8-3.0) | 0.177 |
| Peripheral vascular disease, | 28 (6.6) | 8 (5.8) | 20 (6.9) | 0.8 (0.3-1.9) | 0.835 |
| Cancer, | 93 (21.7) | 29 (20.9) | 64 (22.1) | 0.9 (0.5-1.5) | 0.803 |
| Parkinson's disease, | 21 (4.9) | 4 (2.9) | 17 (5.9) | 0.4 (0.1-1.4) | 0.236 |
| Hypothyroidism, | 42 (9.8) | 19 (13.8) | 23 (8.0) | 1.8 (0.9-3.5) | 0.081 |
| Smoking, | 54 (12.6) | 26 (18.8) | 28 (9.7) | 2.1 (1.2-3.8) | 0.012 |
| Laboratory | |||||
| Hemoglobin, g/dl, mean±SD | 11.4±2.0 | 11.3±1.9 | 11.5±2.0 | / | 0.313 |
| Albumin, g/dl, mean±SD | 3.3±0.5 | 3.2±0.5 | 3.3±0.5 | / | 0.062 |
| Calcium, mg/dl, mean±SD | 8.8±0.7 | 8.7±0.7 | 8.9±0.7 | / | 0.008 |
| Potassium, mEq/L, mean±SD | 4.3±0.7 | 4.1±0.6 | 4.4±0.8 | / | <0.0001 |
| Urea, mg/dl, mean±SD | 66.3±50.1 | 69.3±49.8 | 64.8±50.3 | / | 0.383 |
| Creatinine, mg/dl, mean±SD | 1.4±0.8 | 1.5±1.0 | 1.3±0.7 | / | 0.201 |
| Alanine aminotransferase, IU, mean±SD | 35.1±113.7 | 35.2±71.4 | 35.0±129.3 | / | 0.985 |
| Sodium, mEq/L, mean±SD | 135.6±5.2 | 135.7±4.3 | 135.6±5.6 | / | 0.778 |
| Drugs | |||||
| Anti-Parkinson’s, | 28 (6.5) | 8 (5.8) | 20 (6.9) | 0.8 (0.3-1.9) | 0.835 |
| Benzodiazepines, | 157 (36.7) | 60 (43.2) | 97 (33.6) | 1.5 (0.9-2.2) | 0.055 |
| Diuretics, | 156 (36.4) | 48 (34.5) | 108 (37.4) | 0.8 (0.5-1.3) | 0.593 |
| Anti-epileptics, | 26 (6.1) | 15 (10.8) | 11 (3.8) | 3.0 (1.3-6.8) | 0.008 |
| Opiates, | 71 (16.6) | 21 (15.1) | 50 (17.3) | 0.8 (0.4-1.4) | 0.677 |
| Statins, | 152 (35.5) | 46 (33.1) | 106 (36.7) | 0.8 (0.5-1.3) | 0.518 |
| Oral hypoglycemics, | 43 (10.0) | 19 (13.7) | 24 (8.3) | 1.7 (0.9-3.3) | 0.089 |
| Insulin, | 92 (21.5) | 30 (21.6) | 62 (21.5) | 1.0 (0.6-1.6) | 0.999 |
| Nitrates, | 28 (6.6) | 8 (5.8) | 20 (6.9) | 0.8 (0.3-1.9) | 0.835 |
| Neuroleptics, | 62 (14.5) | 22 (15.9) | 40 (13.8) | 1.1 (0.6-2.0) | 0.560 |
| Steroids, | 89 (20.8) | 35 (25.4) | 54 (18.7) | 1.4 (0.9-2.4) | 0.127 |
| ¥Antidepressants, | 80 (18.7) | 24 (17.4) | 56 (19.4) | 0.8 (0.5-1.4) | 0.692 |
| Other data | |||||
| Morse falls score, mean±SD | 16.2±6.1 | 17.3±5.6 | 15.7±6.3 | / | 0.016 |
| Came from nursing home, | 85 (19.9) | 21 (15.1) | 64 (22.1) | 0.6 (0.3-1.0) | 0.094 |
| Falls in the previous 6 months, | 289 (67.5) | 96 (69.1) | 193 (66.8) | 1.1 (0.7-1.7) | 0.661 |
| Functionally Independent, | 105 (24.5) | 27 (19.4) | 78 (27.0) | / | <0.0001 |
| Mildly dependent, | 232 (54.2) | 96 (69.1) | 136 (47.1) | / | |
| Fully dependent, | 91 (21.3) | 16 (11.5) | 75 (26.0) | / | |
| Walking device - no, | 230 (53.7) | 85 (61.2) | 145 (50.2) | / | 0.008 |
| cane, | 59 (13.8) | 24 (17.3) | 35 (12.1) | / | |
| walker, | 70 (16.4) | 17 (12.2) | 53 (18.3) | / | |
| wheelchair, | 69 (16.1) | 13 (9.4) | 56 (19.4) | / | |
SD standard deviation; ¥Including SSRI and SNRI
Binary regression analysis showing which variables were independently associated with increased and decreased risk of in-hospital falls
| Beta | Standard error | Odds ratio | 95% confidence interval | p value | |
|---|---|---|---|---|---|
| Associated with increased risk of falling | |||||
| Mildly dependent | 1.385 | 0.359 | 3.99 | 1.97-8.08 | <0.0001 |
| Anti-epileptics | 1.362 | 0.537 | 3.90 | 1.36-11.18 | 0.011 |
| Hypothyroidism | 1.300 | 0.417 | 3.66 | 1.62-8.30 | 0.002 |
| Oral hypoglycemic | 0.972 | 0.455 | 2.64 | 1.08-6.45 | 0.033 |
| Morse falls score | 0.069 | 0.025 | 1.07 | 1.01-1.12 | 0.007 |
| Associated with decreased risk of falling | |||||
| Atrial fibrillation | −0.705 | 0.336 | 0.49 | 0.25-0.95 | 0.036 |
| Potassium | −0.910 | 0.216 | 0.40 | 0.26-0.61 | <0.0001 |
| Walking with a walker | −1.191 | 0.422 | 0.30 | 0.13-0.69 | 0.005 |
| Using a wheelchair | −1.366 | 0.431 | 0.25 | 0.11-0.59 | 0.002 |
Fig. 1A receiver operating characteristic (ROC) curve analysis showing the Modified Morse Fall Scale scores prediction values before (a) and after (b) incorporation of all relevant variables